Phreesia, Inc. logo

PHR Earnings Date: Dec 14, 2026 (Estimated) — Phreesia, Inc.

NYSE · Healthcare · Health Information Services

Updated

Price $12.53
Market Cap $777.7M
P/E 63.5
52W Range $7.77 – $24.07
Next Earnings · After close (est.)

When is PHR's next earnings date?

Phreesia, Inc. (PHR) is expected to report Q3 2027 earnings on Monday, December 14, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.31 on revenue of $128.2M.

How did PHR do in its last earnings report?

In its most recent report on Sep 2, 2026 (Q2 2027), Phreesia, Inc. posted EPS of $0.03 versus the $0.09 estimate, a miss of 89.3%. Revenue was $129.5M against a $129.1M estimate. The stock's 1-day post-earnings move was -6.3%.

How much does PHR stock move after earnings?

PHR beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 11.8% (up or down) in the day after earnings.

About Phreesia, Inc.

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-09-02Q2 20270.090.03-89.29%$129.5M❌ Miss-6.33%-14.18%-15.02%
2026-05-27Q1 20270.230.05-78.26%$130.9M❌ Miss+3.50%+5.70%+10.30%
2026-03-30Q4 20260.230.02-91.30%$127.1M❌ Miss-26.56%-20.60%-17.88%
2025-12-08Q3 20260.240.07-70.83%$120.3M❌ Miss-23.31%-17.00%-16.00%
2025-09-04Q2 20260.090.01-88.89%$117.3M❌ Miss-9.87%-18.36%-25.44%
2025-03-12Q4 2025-0.19-0.11+42.11%$109.7M✅ Beat+6.93%+21.85%+0.84%
2024-12-09Q3 2025-0.29-0.25+13.79%$106.8M✅ Beat+11.60%+18.54%+23.35%
2024-09-04Q2 2025-0.36-0.31+13.89%$102.1M✅ Beat+6.29%-3.52%-8.69%

Showing last 8 quarters.

Revenue by segment & region

By segment

Q2 FY27 · $129.5M total

SegmentShareRevenueYoY
Subscription And Services40.7%$52.7M-1.9%
Payment Solutions29.7%$38.5M—
Network Solutions29.6%$38.3M+8.9%

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .